Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines provide essential tools for the control of the COVID-19 pandemic. A number of technologies have been employed to develop SARS-CoV-2 vaccines, including the inactivated SARS-CoV-2 particles, mRNA to express viral spike protein, rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Shan, Fan, Zhangling, Liu, Xiaoman, Zhao, Fei, Huang, Yu, Wei, Liang, Hu, Yamei, Xie, Yu, Wang, Liming, Ai, Bin, Liang, Chen, Xu, Fengwen, Guo, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353262/
https://www.ncbi.nlm.nih.gov/pubmed/35935962
http://dx.doi.org/10.3389/fimmu.2022.911164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353262/
https://www.ncbi.nlm.nih.gov/pubmed/35935962
http://dx.doi.org/10.3389/fimmu.2022.911164

Ejemplares similares